Introduction Lifestyle-related non-communicable chronic diseases are the major causes of morbidity and mortality in both developed and developing countries. The major interrelated chronic diseases that have an impact on the population include hypertension, obesity, dyslipidemia, diabetes, and the metabolic syndrome. These diseases are more prevalent worldwide. The estimated global age-standardized prevalence of hypertension in adults aged ≥20 years in 2010 was 31.1%. [1] 39% of adults aged ≥18 years were overweight in 2016, and 13% were obese. [2] The prevalence of dyslipidemia was 34.0% in China and 15% in America. [3,4] The total number of diabetics aged 20-79 years worldwide was 425 million in 2017, accounting for 8.8% of the total. [5] Even more intractable is that these diseases do not exist alone, they interact with one another and damage end organs together, such as the heart, brain, kidney, and eye. It leads to coronary artery disease (CAD), cerebrovascular disease (CVD), chronic kidney disease (CKD), and retinopathy and contributes to the overall chronic disease burden. [6] Among these chronic diseases, hypertension is the biggest global health challenge due to its high prevalence and resulting target organs damage. [1] Hypertension affects >1 billion people worldwide, ranking third in terms of the global burden of disease. [7] It is the predominant risk factor for mortality in both industrialized nations and low-or middle-income countries. Hypertension is responsible for more than half of deaths from stroke, and 45% of deaths from CAD, and, alarmingly, for more than one-tenth of all global deaths. [8] Hypertension also accounts for up to one-fifth of end-stage renal disease in developing countries [9,10] and for CKD affecting 7% of the world's population. [9] Therefore, it is necessary to improve the current methods of identification, prevention, and treatment of hypertension and reduce the mortality from its complications. While we can identify these conditions, it is not so clear how we can assess the burden of these chronic diseases (end-organ damage) and its relationship to hypertension. For example, clinical practice guidelines recommend using urine albuminto-creatinine ratio as a means to detect target organ damage by